![Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12872-020-01843-0/MediaObjects/12872_2020_1843_Fig1_HTML.png)
Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text
![Successful treatment of arrhythmia with β‐blocker and flecainide combination in pregnant patients with Andersen–Tawil syndrome: A case report and literature review - Rujirachun - 2021 - Annals of Noninvasive Electrocardiology - Wiley Online Library Successful treatment of arrhythmia with β‐blocker and flecainide combination in pregnant patients with Andersen–Tawil syndrome: A case report and literature review - Rujirachun - 2021 - Annals of Noninvasive Electrocardiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fec797ed-920d-451e-9f70-319648f2ba61/anec12798-fig-0001-m.png)
Successful treatment of arrhythmia with β‐blocker and flecainide combination in pregnant patients with Andersen–Tawil syndrome: A case report and literature review - Rujirachun - 2021 - Annals of Noninvasive Electrocardiology - Wiley Online Library
![High-dose flecainide with low-dose β-blocker therapy in catecholaminergic polymorphic ventricular tachycardia: A case report and review of the literature - ScienceDirect High-dose flecainide with low-dose β-blocker therapy in catecholaminergic polymorphic ventricular tachycardia: A case report and review of the literature - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1878540914001042-gr1.jpg)
High-dose flecainide with low-dose β-blocker therapy in catecholaminergic polymorphic ventricular tachycardia: A case report and review of the literature - ScienceDirect
![Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12872-020-01843-0/MediaObjects/12872_2020_1843_Fig2_HTML.png)
Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text
![Echo, Stress Test, CMRI all clear, Beta Blocker didn't work, on 150mg Flecainide 2x/Day. 3% Burden, told not enough for ablation. Any suggestions? : r/PVCs Echo, Stress Test, CMRI all clear, Beta Blocker didn't work, on 150mg Flecainide 2x/Day. 3% Burden, told not enough for ablation. Any suggestions? : r/PVCs](https://preview.redd.it/echo-stress-test-cmri-all-clear-beta-blocker-didnt-work-on-v0-5od0p46un3s91.jpg?auto=webp&s=ba4c5490beb6a90cf0060f4de10f25641c847ffb)
Echo, Stress Test, CMRI all clear, Beta Blocker didn't work, on 150mg Flecainide 2x/Day. 3% Burden, told not enough for ablation. Any suggestions? : r/PVCs
![Anyone try flecainide? Failed beta blockers and now failing high dose calcium channel blockers. : r/PVCs Anyone try flecainide? Failed beta blockers and now failing high dose calcium channel blockers. : r/PVCs](https://i.redd.it/wfenutso7do51.jpg)
Anyone try flecainide? Failed beta blockers and now failing high dose calcium channel blockers. : r/PVCs
![This drug has beta-adrenergic blocking activity: a) Flecainide b) Sotalol c) Lidocaine d) Verapamil | Homework.Study.com This drug has beta-adrenergic blocking activity: a) Flecainide b) Sotalol c) Lidocaine d) Verapamil | Homework.Study.com](https://homework.study.com/cimages/videopreview/videopreview-full/sv9qrv2zli.jpg)
This drug has beta-adrenergic blocking activity: a) Flecainide b) Sotalol c) Lidocaine d) Verapamil | Homework.Study.com
Beta1-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation | PLOS ONE
![JCM | Free Full-Text | Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs JCM | Free Full-Text | Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs](https://pub.mdpi-res.com/jcm/jcm-11-03233/article_deploy/html/images/jcm-11-03233-g001.png?1654572884)
JCM | Free Full-Text | Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs
![PDF) Flecainide–metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation PDF) Flecainide–metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation](https://i1.rgstatic.net/publication/295074372_Flecainide-metoprolol_combination_reduces_atrial_fibrillation_clinical_recurrences_and_improves_tolerability_at_1-year_follow-up_in_persistent_symptomatic_atrial_fibrillation/links/5a58df9baca2727d608151e8/largepreview.png)
PDF) Flecainide–metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation
![Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration - International Journal of Cardiology Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration - International Journal of Cardiology](https://www.internationaljournalofcardiology.com/cms/asset/8673c402-b5e2-453f-9f98-aa60a3c8cfdb/gr1.jpg)
Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration - International Journal of Cardiology
![Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia | Revista Española de Cardiología Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1885585717303560:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1NAWe0Nuoe8XVWAXbQijr7S/8v4Dk30tYR6zte0KlP32n2zxqQnXg2HYPH7I+uIl57v5NBauwfCbjtZ8vhdG/X4xU5tZtmAh1t3GO4t+Wy6/egrZ5cXCv5IRSE7s3eM4/++Wn7HIRzZjy5zII8O4EGzqzMFhrYaVVsqXgTd4/ajXTaX8pHm8UsPbiyQGVhZXdUo7cyIzgXX2AuLcQETcBl/o8wfjLLt4Yo1eHB9Gl865U=)
Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia | Revista Española de Cardiología
![Enlightened Medical Management of Atrial Fibrillation, Part III: Flecainide for Chronic Suppression – The Skeptical Cardiologist Enlightened Medical Management of Atrial Fibrillation, Part III: Flecainide for Chronic Suppression – The Skeptical Cardiologist](https://i0.wp.com/theskepticalcardiologist.com/wp-content/uploads/2020/06/WJC-7-76-g002.jpg?fit=613%2C513&ssl=1)